Icon

ZAVESCA (nda021348)- (100MG)

MIGLUSTAT ACTELION
100MG
No No
2013-Jun-11 Expired
2010-Jul-31 None
None No
ZAVESCA is a glucosylceramide synthase inhibitor indicated as monotherapy for treatment of adult patients with mild/moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option.
3 0 3
Total Other Developers 3
Drugs with Suitability No
100MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ****** ****** ******** ************** **., ***. *********** **. **, ******* *** ****, ****** ********** ****, ******, ******* ******, ***** (***) ***
****** ************ ******** ******** - ************, *** *********** * ******* **** *** ***, ********, ************ (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.